Sttr phase i: novel acellular grafts containing rifampin and minocycline for single-stage reconstruction of stage II-III pressure ulcers
Ended Project Grant Awarded Last action
- Award ID
- 2012920
- Recipient
-
Bioaesthetics Corporation UEI CB6YT355CQK5
- Awarding agency
-
Division of Industrial Innovation
National Science Foundation
- Obligated
- $251,208
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Originally
- Funding agency
- National Science Foundation
- Place of performance
- Research Triangle Park, Durham, NC, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $251,208 |
Quick answers
Who received award 2012920?
2012920 was awarded to Bioaesthetics Corporation by Division of Industrial Innovation (National Science Foundation) on October 15, 2020.
How much is award 2012920 worth?
$251,208 has been obligated on 2012920.
Which agency awarded 2012920?
Division of Industrial Innovation (National Science Foundation) awarded 2012920, with funding from National Science Foundation.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award